Krishna Institute of Medical Sciences Limited

NSEI:KIMS Lagerbericht

Marktkapitalisierung: ₹238.2b

Krishna Institute of Medical Sciences Zukünftiges Wachstum

Future Kriterienprüfungen 5/6

Krishna Institute of Medical Sciences wird ein jährliches Gewinn- und Umsatzwachstum von 24.3% bzw. 21.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 1.8% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 19.3% betragen.

Wichtige Informationen

24.3%

Wachstumsrate der Gewinne

1.8%

EPS-Wachstumsrate

Healthcare Gewinnwachstum27.3%
Wachstumsrate der Einnahmen21.9%
Zukünftige Eigenkapitalrendite19.3%
Analystenabdeckung

Good

Zuletzt aktualisiert21 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Nov 13
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump

Sep 05
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump

We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right

Aug 23
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right

Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Aug 10
Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?

Jul 02
Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt?

Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Jun 12
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon

Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

Apr 28
Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist?

We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Apr 10
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS)

Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Feb 29
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS)

Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 08
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate

Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Nov 21
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist

Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Aug 23
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention?

Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Aug 02
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS)

Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Apr 01
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher

Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Dec 14
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital

Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Aug 13
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report

Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Aug 12
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency

Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Jul 02
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors

Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

May 08
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected

Gewinn- und Umsatzwachstumsprognosen

NSEI:KIMS - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (INR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
3/31/202746,7296,1985,0769,63411
3/31/202638,1864,6322,5657,60013
3/31/202530,7983,913-4,9716,60211
9/30/202427,0533,313-2,4094,964N/A
6/30/202425,8053,159N/AN/AN/A
3/31/202424,9813,101-1,2625,211N/A
12/31/202324,4033,379N/AN/AN/A
9/30/202323,9663,421-2,2634,621N/A
6/30/202323,0823,472N/AN/AN/A
3/31/202321,9773,363-1,4244,321N/A
12/31/202219,9413,237N/AN/AN/A
9/30/202218,2553,2897413,693N/A
6/30/202216,7323,135N/AN/AN/A
3/31/202216,5083,3271,5373,240N/A
12/31/202116,3703,098N/AN/AN/A
9/30/202116,0412,7742,3183,488N/A
6/30/202116,0202,792N/AN/AN/A
3/31/202113,2992,0122,6153,560N/A
12/31/202012,4121,7213,1803,774N/A
3/31/202011,2271,1921,4952,015N/A
3/31/20199,204-4775661,339N/A
3/31/20186,652-474N/A1,058N/A
3/31/20175,689326N/A815N/A
3/31/20165,145266N/A955N/A
3/31/20154,22256N/A639N/A
3/31/20143,56969N/A778N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: KIMSDas prognostizierte Gewinnwachstum (24.3% pro Jahr) liegt über der Sparquote (6.7%).

Ertrag vs. Markt: KIMSDie Erträge des Unternehmens (24.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (18% pro Jahr).

Hohe Wachstumserträge: KIMSEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: KIMSDie Einnahmen des Unternehmens (21.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.5% pro Jahr).

Hohe Wachstumseinnahmen: KIMSDie Einnahmen des Unternehmens (21.9% pro Jahr) werden voraussichtlich schneller wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: KIMSDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (19.3%).


Wachstumsunternehmen entdecken